Cardiol Therapeutics Inc. SEC filings CRDL

Cardiol Therapeutics Inc. has 188 filings in SEC EDGAR's recent list, going back to Mar 29, 2017. Its latest annual report, Form 40-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

Cardiol Therapeutics Inc. SEC filings
Form Description Filed Period
SUPPL Filing Nov 3, 2026 —
SUPPL Filing Sep 16, 2026 —
SUPPL Filing Nov 5, 2025 —
D Filing Nov 4, 2025 —
SUPPL Filing Oct 9, 2024 —
SUPPL Filing Oct 8, 2024 —
EFFECT Filing Jul 16, 2024 —
SUPPL Filing Jul 16, 2024 —
SUPPL Filing Jun 9, 2022 —
SUPPL Filing Feb 8, 2022 —
SUPPL Filing Nov 4, 2021 —
SUPPL Filing Nov 4, 2021 —
SUPPL Filing Nov 2, 2021 —
CERT 8a cert Aug 10, 2021 —
8-A12B/A Form 8-a12b/a Aug 9, 2021 —
EFFECT Filing Aug 4, 2021 —
8-A12B Form 8-a12b Aug 4, 2021 —
D Filing Dec 15, 2020 —
D Filing Jan 4, 2019 —
D Filing Sep 29, 2017 —
D Filing Mar 29, 2017 —

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CRDL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ontario, Canada
Headquarters
Oakville, Ontario, Canada
SEC filer status
, Emerging growth company
SEC CIK
1702123

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.